81%
(95% CI 64%-91%)
88%
(95% CI 67%-96%)
5y results
62 patients, Median follow-up: 43 months (range, 1-81)
98%
(95% CI 89%-100%)
Local Control
PFS
OS
Application: ?? 2 dose levels in some
PET+ve cases
(20-30 Gy pre-chemo, 36 - 40Gy to residual PET+ve sites)